-
Mashup Score: 1Estudio clínico salva la vida de paciente con cáncer de páncreas - UHealth Collective - 7 month(s) ago
La Dra. Gretel Terrero, oncóloga gastrointestinal, habla sobre el beneficio de inmunoterapias en cierto tipo de tumores pancreáticos.
Source: news.umiamihealth.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 86Peter Hosein, MD - V Foundation - 7 month(s) ago
Funded in partnership with Miami Dolphins Foundation Pancreatic cancer is a really bad disease that’s hard to treat. Even though treatments like immunotherapy have helped with other cancers, they haven’t worked well for pancreatic cancer. Some people get pancreatic cancer because of a problem gene passed down in their family, like BRCA. We tried treating […]
Source: www.v.orgCategories: General Medicine News, Hem/OncsTweet-
Very grateful to @TheVFoundation and @MiamiDolphins for supporting my indomitable co-PI @DrJashDatta and I as we attempt to make further inroads into #PancreaticCancer #pancsm @SylvesterCancer #InPursuitOfYourCure #SPCRI https://t.co/XKjEuN7UkU
-
-
Mashup Score: 8ClinicalTrials.gov - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
First: Trials in progress Poster on our IIT testing MEK, STAT3 and PD1 inhibition in metastatic pancreas cancer https://t.co/aMTGb1ziVW https://t.co/kEjy4NKYf3
-
-
Mashup Score: 34Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review - 1 year(s) ago
Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review
Source: jgo.amegroups.orgCategories: General Medicine News, Hem/OncsTweet-
Shout out the great and very humble @UmJmhIMRes #HengTanMD for getting this review paper to the finish line. Check it out for everything you always wanted to know about HRD in #PancSM and were afraid to ask! @SylvesterCancer #WageHope https://t.co/Vy7bHR2UFl
-
-
Mashup Score: 0
Co-occurrent KRAS and TP53 mutations define a majority of patients with pancreatic ductal adenocarcinoma (PDAC) and define its pro-metastatic proclivity. Here, we demonstrate that KRAS-TP53 co-alteration is associated with worse survival compared with either KRAS-alone or TP53-alone altered PDAC in …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
@Aiims1742 @HPolymenis @FoundationATCG Perhaps @DrJashDatta might have a thought or two about this https://t.co/bwRuh7d7oh
-
-
Mashup Score: 0Cherishing the Simple Things - 2 year(s) ago
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
Source: Let's Win! Pancreatic CancerCategories: Hem/Oncs, Latest HeadlinesTweet-
@Aiims1742 Case 6: PDAC with germline PALB2, CR with immunotherapy https://t.co/gDJlsTXhxN
-
-
Mashup Score: 0Immunotherapy Study Offers Hope for Pancreatic Cancer Patients - 3 year(s) ago
In a research letter to the journal JAMA Oncology, clinical researchers at Sylvester Comprehensive Cancer Center in the University of Miami Miller School of Medicine showed that immunotherapy can be an option for at least one subgroup of pancreatic cancer patients. The study found that patients…
Categories: Latest Headlines, Oncologists2Tweet-
More details from one of the patients in our recent publication who graciously agreed to share his story to help others #WageHope https://t.co/hOOsejiZFV
-
-
Mashup Score: 0Cherishing the Simple Things - 3 year(s) ago
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
Source: Let's Win! Pancreatic CancerCategories: Latest Headlines, Oncologists2Tweet-
Linking this recent story about another patient with a PALB2 mutation who was treated in a similar fashion @HRInstitute_AZ and responded well: https://t.co/aKex6FaEHM
-
-
Mashup Score: 13Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With HRD PGVs - 3 year(s) ago
This case series describes ipilimumab/nivolumab therapy in patients with metastatic pancreatic or biliary cancer with homologous recombination deficiency (HRD) pathogenic germline variants (PGVs).
Source: jamanetwork.comCategories: Latest Headlines, Oncologists2Tweet-
Happy to share the latest publication from our team @SylvesterCancer examining immunotherapy in patients with pancreas cancer with homologous recombination deficiency (mostly BRCA1/2 and RAD51C) out today in @JAMAOnc https://t.co/AGnaizwydQ
-
-
Mashup Score: 5
Please join us for our first international virtual pancreatic cancer symposium on January 28th, 2022. This symposium brings together pancreatic cancer experts to provide the most up-to-date information on the diagnosis, staging, and state-of-the-art treatments. See below for a PDF Agenda with all topics and speakers.Speakers: – Peter Hosein, MD, University of Miami: Making Inroads into…
Source: ocpe.mcw.eduCategories: Latest Headlines, Oncologists2Tweet-
Looking forward to sharing the stage with this fantastic group of pancreas aficionados at the Annual MCW Pancreatic Cancer Symposium on Jan 28th @MCWPancProgram Register here: https://t.co/rnOOtB53to https://t.co/6D7S35Tysr
-
Conocer la Dra. Terrero un poco mas 👇 https://t.co/X09WJwaqSy